Full Text View
Tabular View
No Study Results Posted
Related Studies
Improvement of Erectile Dysfunction by Fluvastatin in Patients With Cardiovascular Risk Factors
This study has been withdrawn prior to enrollment.
( not enough patients meeting inclusion criteria )
Study NCT00382161   Information provided by University Hospital, Saarland

First Received on September 27, 2006.   Last Updated on February 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Impotence
Additional conditions recognized in this trial
Erectile Dysfunction
More general conditions related to this trial
Genital Diseases, Male
Mental Disorders
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Interventions listed in this trial
Fluvastatin-sodium
Additional drug interventions recognized in this trial
Fluvastatin
Hydroxymethylglutaryl-CoA Reductase Inhibitors
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University Hospital, Saarland
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services